Monthly News Roundup - July 2017

FDA Approves Gilead ’s Vosevi for Six Hepatitis C Genotypes The U.S. Food and Drug Administration (FDA) has approved Gilead’s Vosevi (sofosbuvir, velpatasvir and voxilaprevir) for retreatment of adults with chronic hepatitis C virus (HCV) of...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news